Targeted therapy for breast cancer: Pros and cons

By Mayo Clinic staff

ProsCons
Reduces risk of recurrence by about half in early-stage HER2-positive breast cancer Not effective for breast cancers that are HER2-negative
  Increases risk of congestive heart failure
  Extraordinarily expensive, but usually covered by insurance

MY00202

Aug. 5, 2008

© 1998-2010 Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. A single copy of these materials may be reprinted for noncommercial personal use only. "Mayo," "Mayo Clinic," "MayoClinic.com," "EmbodyHealth," "Enhance your life," and the triple-shield Mayo Clinic logo are trademarks of Mayo Foundation for Medical Education and Research.


Text Size: smaller largerlarger